Clinicopathologic features and outcomes of metaplastic breast Carcinoma: Comparison with invasive ductal carcinoma of the breast

Yonsei Medical Journal

Volumn 51, Issue 6, 2010, Pages 864-869

  Park, Hyung Seok ^a   Park, Seho ^a   Kim, Joo Hee ^a   Lee, Ju Hyun ^a   Choi, So Young ^a   Park, Byeong Woo ^a   Lee, Kyong Sik ^b  

^a Yonsei University College of Medicine   (South Korea)

^b CHA University   (South Korea)

Author keywords

Breast neoplasms; Metaplasia; Survival; Triple negative breast cancer

Indexed keywords

ADULT; AGED; BREAST CARCINOMA; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; LYMPH NODE METASTASIS; METAPLASIA; METAPLASTIC BREAST CARCINOMA; NEEDLE BIOPSY; OVERALL SURVIVAL; PREOPERATIVE EVALUATION; PROGNOSIS; RARE DISEASE; REVIEW; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TUMOR VOLUME;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; INCIDENCE; MEDICAL ONCOLOGY; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; RECURRENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 77957948217     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2010.51.6.864     Document Type: Review

References (35)

1. Oberman HA. Metaplastic carcinoma of the breast. A clinicopathologic study of 29 patients. Am J Surg Pathol 1987;11:918-29.
2. Wargotz ES, Deos PH, Norris HJ. Metaplastic carcinomas of the breast. II. Spindle cell carcinoma. Hum Pathol 1989;20:732-40.
3. Wargotz ES, Norris HJ. Metaplastic carcinomas of the breast. III. Carcinosarcoma. Cancer 1989;64:1490-9.
4. Wargotz ES, Norris HJ. Metaplastic carcinomas of the breast. I. Matrix-producing carcinoma. Hum Pathol 1989;20:628-35.
5. Wargotz ES, Norris HJ. Metaplastic carcinomas of the breast: V. Metaplastic carcinoma with osteoclastic giant cells. Hum Pathol 1990;21:1142-50.
6. Wargotz ES, Norris HJ. Metaplastic carcinomas of the breast. IV. Squamous cell carcinoma of ductal origin. Cancer 1990;65:272-6.
7. Beatty JD, Atwood M, Tickman R, Reiner M. Metaplastic breast cancer: clinical significance. Am J Surg 2006;191:657-64.
8. Chao TC, Wang CS, Chen SC, Chen MF. Metaplastic carcinomas of the breast. J Surg Oncol 1999;71:220-5.
9. Gutman H, Pollock RE, Janjan NA, Johnston DA. Biologic distinctions and therapeutic implications of sarcomatoid metaplasia of epithelial carcinoma of the breast. J Am Coll Surg 1995;180: 193-9.
10. Bellino R, Arisio R, D'Addato F, Attini R, Durando A, Danese S, et al. Metaplastic breast carcinoma: pathology and clinical outcome. Anticancer Res 2003;23:669-73.
11. Khan HN, Wyld L, Dunne B, Lee AH, Pinder SE, Evans AJ, et al. Spindle cell carcinoma of the breast: a case series of a rare histological subtype. Eur J Surg Oncol 2003;29:600-3.
12. Reis-Filho JS, Milanezi F, Steele D, Savage K, Simpson PT, Nesland JM, et al. Metaplastic breast carcinomas are basal-like tumours. Histopathology 2006;49:10-21.
13. Rakha EA, Ellis IO. Triple-negative/basal-like breast cancer: review. Pathology 2009;41:40-7.
14. Korsching E, Jeffrey SS, Meinerz W, Decker T, Boecker W, Buerger H. Basal carcinoma of the breast revisited: an old entity with new interpretations. J Clin Pathol 2008;61:553-60.
15. Irvin WJ Jr, Carey LA. What is triple-negative breast cancer? Eur J Cancer 2008;44:2799-805.
16. Barnes PJ, Boutilier R, Chiasson D, Rayson D. Metaplastic breast carcinoma: clinical-pathologic characteristics and HER2/neu expression. Breast Cancer Res Treat 2005;91:173-8.
17. Tavassoli FA. Classification of metaplastic carcinomas of the breast. Pathol Annu 1992;27 Pt 2:89-119.
18. Park JH, Han W, Kim SW, Lee JE, Shin HJ, Kim SW, et al. The clinicopathologic characteristics of 38 metaplastic carcinomas of the breast. J Breast Cancer 2005;8:59-63.
19. Pezzi CM, Patel-Parekh L, Cole K, Franko J, Klimberg VS, Bland K. Characteristics and treatment of metaplastic breast cancer: analysis of 892 cases from the National Cancer Data Base. Ann Surg Oncol 2007;14:166-73.
20. Son BH, Ahn SH. Survival Analysis of Korean Breast Cancer Patients Diagnosed between 1993 and 2002 in Korea - A Nationwide Study of the Cancer Registry. J Breast Cancer 2006;9:214- 229.
21. Kim EY, Lee S, Bae TS, Kim SW, Kwon Y, Kim EA, et al. The clinical characteristics and predictive factors of stage IV breast cancer at the initial presentation: a review of a single institute's data. J Breast Cancer 2007;10:5.
22. Gilbert JA, Goetz MP, Reynolds CA, Ingle JN, Giordano KF, Suman VJ, et al. Molecular analysis of metaplastic breast carcinoma: high EGFR copy number via aneusomy. Mol Cancer Ther 2008;7:944-51.
23. Rayson D, Adjei AA, Suman VJ, Wold LE, Ingle JN. Metaplastic breast cancer: prognosis and response to systemic therapy. Ann Oncol 1999;10:413-9.
24. Geyer FC, Weigelt B, Natrajan R, Lambros MB, de Biase D, Vatcheva R, et al. Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomas. J Pathol 2010;220:562-73.
25. Leibl S, Moinfar F. Metaplastic breast carcinomas are negative for Her-2 but frequently express EGFR (Her-1): potential relevance to adjuvant treatment with EGFR tyrosine kinase inhibitors? J Clin Pathol 2005;58:700-4.
26. Kim MJ, Ro JY, Ahn SH, Kim HH, Kim SB, Gong G. Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neuoverexpressing phenotypes. Hum Pathol 2006;37:1217-26.
27. Chhieng C, Cranor M, Lesser ME, Rosen PP. Metaplastic carcinoma of the breast with osteocartilaginous heterologous elements. Am J Surg Pathol 1998;22:188-94.
28. Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature 2000;406:747-52.
29. Sørlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 2001;98:10869-74.
30. Luini A, Aguilar M, Gatti G, Fasani R, Botteri E, Brito JA, et al. Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: the experience of the European Institute of Oncology and review of the literature. Breast Cancer Res Treat 2007;101:349-53.
31. Kuroda N, Fujishima N, Inoue K, Ohara M, Hirouchi T, Mizuno K, et al. Basal-like carcinoma of the breast: further evidence of the possibility that most metaplastic carcinomas may be actually basal-like carcinomas. Med Mol Morphol 2008;41:117-20.
32. Garcia S, Dalès JP, Charafe-Jauffret E, Carpentier-Meunier S, Andrac-Meyer L, Jacquemier J, et al. Poor prognosis in breast carcinomas correlates with increased expression of targetable CD146 and c-Met and with proteomic basal-like phenotype. Hum Pathol 2007;38:830-41.
33. Weigelt B, Kreike B, Reis-Filho JS. Metaplastic breast carcinomas are basal-like breast cancers: a genomic profiling analysis. Breast Cancer Res Treat 2009;117:273-80.
34. Park JM, Han BK, Moon WK, Choe YH, Ahn SH, Gong G. Metaplastic carcinoma of the breast: mammographic and sonographic findings. J Clin Ultrasound 2000;28:179-86.
35. Lien HC, Hsiao YH, Lin YS, Yao YT, Juan HF, Kuo WH, et al. Molecular signatures of metaplastic carcinoma of the breast by large-scale transcriptional profiling: identification of genes potentially related to epithelial-mesenchymal transition. Oncogene 2007;26:7859-71.